What Are the Signs of Kidney Cancer? Simply Explained

The signs of kidney cancer and even the thought of it can feel scary. But knowing the warning signs helps you catch it early, when treatment works best. Many people miss the subtle signals their bodies send. Symptoms often appear gradually or get mistaken for less serious conditions.

This article walks you through everything from the earliest warning signs to advanced stages. It helps you understand when to talk with your doctor. Whether you're monitoring your health at home or supporting someone you care about, recognizing these signs could make all the difference.

Key Insights

• Blood in urine appears in about 50% of kidney cancer cases and often shows up without pain

• The classic triad of symptoms (blood in urine, back pain, abdominal mass) only occurs in 10-15% of patients

• More than half of kidney cancers get found accidentally during scans for unrelated health issues

• Stage 4 kidney cancer spreads most commonly to lungs (50%), bones (30%), and liver (20%)

• At-home urine strips can detect blood in urine but cannot diagnose kidney cancer on their own

• Survival rates drop from 93% at stage 1 to 12% at stage 4, making early detection vital

What Are the Common Signs of Kidney Cancer to Watch For?

Kidney cancer shows up differently in each person. Sometimes it hides in plain sight. The most recognizable signs include blood in your urine, persistent pain in your lower back or side, and unexplained weight loss. These symptoms develop because tumors can bleed, press against nearby tissues, or disrupt your body's normal functions.

About 60% of kidney cancers get discovered before causing any symptoms. Doctors find them during imaging tests like CT scans or ultrasounds ordered for completely different reasons. You could have kidney cancer without feeling sick. That's why regular check-ups matter.

Warning signs to pay attention to:

• Pink, red, or cola-colored urine from blood (called hematuria, which is present in about 5-20% of cases)

• Constant ache or pressure below your ribs on one side that won't go away

• A lump or hard mass you can feel in your side or belly

• Losing 10 pounds or more without trying

• Feeling exhausted all the time despite adequate sleep

• Fever that comes and goes without infection

• Swelling in your ankles and legs that doesn't improve

These symptoms don't automatically mean cancer. Kidney stones, infections, and other kidney problems cause similar issues. But if any of these last more than two weeks, schedule an appointment with your healthcare provider.

What Are the Early Symptoms of Kidney Cancer?

Early kidney cancer symptoms can be tricky to spot. Your kidneys sit deep in your body, protected by muscles and other organs. Small tumors often grow unnoticed. When symptoms appear early, they're usually mild and easy to dismiss.

Blood in your urine is one of the common early warning signs. It might show up as just a hint of pink one day. Then it disappears for weeks or months before returning. This on-and-off pattern makes people think it's nothing serious. But any blood in your urine deserves a doctor's attention.

Other early signs:

• Dull ache in your side that feels different from muscle soreness

• Feeling full or bloated after eating small amounts

• Low-grade fever around 100°F that lingers without cold or flu symptoms

• High blood pressure that suddenly appears or becomes harder to control

• Anemia showing up in routine blood work without obvious cause

Young adults and people under 50 rarely think about kidney cancer. But it happens at any age. Men get diagnosed more often than women. Smoking doubles your risk. If you have a family history of kidney cancer or inherited conditions like Von Hippel-Lindau disease, stay alert to these early signs.

How to Spot Kidney Cancer Sooner?

Catching kidney cancer sooner starts with paying attention to changes in your body. Keep a simple health journal on your phone. Note unusual symptoms, even minor ones. When something persists for more than two weeks, call your doctor.

Schedule annual physicals that include:

• Blood pressure monitoring (sudden increases can signal kidney issues)

• Complete blood count to check for anemia

• Urine analysis to look for hidden blood or protein

• Discussion of any new or ongoing symptoms, no matter how small they seem

People with higher risk factors should consider imaging tests every few years. This includes anyone with a strong family history, genetic conditions affecting kidneys, or long-term kidney disease. Talk with your doctor about creating a monitoring schedule that makes sense for your situation

What Are the Silent Signs of Kidney Cancer Often Overlooked?

Silent signs are sneaky symptoms that people blame on aging, stress, or busy lifestyles. These quiet signals often appear months before obvious symptoms. They're subtle and easy to dismiss.

Persistent tiredness that doesn't improve with rest gets overlooked most often. This isn't regular end-of-day exhaustion. It's bone-deep fatigue. Getting through normal daily activities feels like running a marathon. Your body works overtime to deal with cancer, leaving less energy for everything else.

Loss of appetite and unexplained weight loss happen gradually. Your clothes fit looser. You've been skipping meals without meaning to. Cancer cells change how your body processes nutrients and make you feel full faster.

Other silent signs:

• Night sweats that soak through pajamas and sheets regularly

• Anemia causing pale skin, weakness, and shortness of breath during normal activities

• Swelling in legs and ankles without standing all day or eating salty foods

• Changes in urination patterns—going more often at night or burning sensations

• Consistent low-grade fever your body can't shake

• High calcium levels in blood tests causing confusion, extreme thirst, or stomach problems

Women sometimes mistake these symptoms for menopause or hormonal changes. Men might attribute them to getting older or working too hard. The key difference is persistence. These symptoms stick around and gradually worsen. They don't come and go with stress or activity levels.

Three Early Symptoms of Renal Cell Carcinoma You Shouldn't Miss

Renal cell carcinoma makes up about 90% of all kidney cancers. Three specific early symptoms deserve special attention. Catching them early dramatically improves treatment success.

First, intermittent blood in urine creates the biggest red flag. The blood might appear bright red, pink, or brownish. What makes it tricky is the random pattern. You see it once, then not again for months. This tricks people into thinking it resolved itself. But kidney tumors bleed on and off as they grow.

Second, pain that starts in your flank area signals something deeper. The flank area is the space between your ribs and hips on your back. This pain doesn't respond to usual remedies. It feels different from muscle strain. It stays constant or comes in waves. Changing positions doesn't help. The tumor pressing against kidney tissue causes this specific discomfort.

Third, a noticeable mass or fullness in your abdomen or side needs immediate attention. You can feel it through your skin. By the time you feel a kidney tumor through your body wall, it has grown considerably. Press gently around your belly and sides. A kidney tumor feels firm and might move slightly when you breathe deeply.

Don't wait for all three symptoms together. The "classic triad" (blood in urine, flank pain, and palpable mass) only happens in 10-15% of cases. Most people experience one or two symptoms, not all three at once.

What is often the first sign of kidney cancer?

Blood in the urine is the first sign most people with kidney cancer notice. This is often called hematuria. It shows up in roughly 50% of kidney cancer diagnoses. The blood makes your urine look pinkish, reddish, or sometimes like tea or cola.

This symptom is important because it usually happens without pain. Kidney stones and bladder infections typically cause painful urination when blood appears. But kidney cancer often bleeds without discomfort. This makes it more concerning.

The bleeding pattern matters. It might appear heavy one day, making your toilet bowl look red. Then it vanishes completely for weeks or months. This disappearing act doesn't mean the problem is gone. The tumor continues growing even when bleeding stops temporarily.

Many people never experience blood in their urine as a first sign. They might notice:

• Unexplained weight loss of 5-10% of body weight over a few months

• Persistent back pain on one side below the rib cage

• Extreme tiredness that interferes with daily activities

• Fever without infection that comes and goes for weeks

In about 30% of cases, kidney cancer gets discovered after spreading beyond the kidney. These people first notice symptoms in other body parts where cancer traveled, persistent cough from lung involvement or bone pain from skeletal spread.

More than half of kidney cancers are found accidentally during imaging tests for unrelated problems.

What advanced kidney cancer means and how does it progress?

Advanced kidney cancer refers to cancer that has grown beyond the kidney or spread to other body parts. Doctors classify this as stage 3 or stage 4 disease. Understanding how cancer moves through your body helps you make sense of symptoms and treatment choices.

Stage 3 kidney cancer means the tumor has grown into major veins near the kidney or spread to nearby lymph nodes. The cancer hasn't reached distant organs yet but is no longer contained within the kidney. Symptoms become more noticeable as the tumor grows larger and affects surrounding tissues.

As cancer advances, it follows predictable pathways:

• Lymph nodes near the kidney get affected first, swelling as they filter out cancer cells

• Blood vessels carrying blood away from kidneys transport cancer cells to distant organs

• The tumor breaks through the kidney's tough outer layer and invades nearby organs

• Cancer cells traveling through bloodstream settle in organs with rich blood supply

Advanced kidney cancer creates symptoms based on spread location. Lung involvement causes persistent cough, chest pain, or coughing up blood. Bone spread leads to pain in specific areas, fractures from weakened bones, or high calcium levels causing confusion and nausea. Liver involvement shows up as jaundice (yellowing skin and eyes), belly pain, or feeling full quickly after eating.

Progression speed varies dramatically between people. Some kidney cancers grow slowly over years. Others advance rapidly in months. Clear cell renal cell carcinoma (the most common type) grows faster than papillary or chromophobe types. Genetic factors, overall health, and treatment timing all influence progression rates.

Stage 4 Kidney Cancer: Symptoms, Spread, and What to Expect?

Stage 4 kidney cancer represents the most advanced form. Cancer has spread to distant organs or multiple lymph nodes far from the kidney. This stage brings the most challenging symptoms because cancer affects multiple body systems at once.

Common symptoms at stage 4:

• Severe fatigue making it hard to complete basic daily tasks

• Significant weight loss of 15-20 pounds or more without trying

• Persistent pain in bones, chest, or abdomen depending on spread locations

• Breathing difficulties if cancer affects lungs

• Swelling throughout body as kidneys struggle to function

• Confusion or mental changes from high calcium levels or brain involvement

• Severe anemia causing extreme weakness and dizziness

At this stage, symptoms come from both the original kidney tumor and spread locations. Treatment focuses on slowing cancer growth, managing symptoms, and maintaining quality of life. Modern targeted therapies and immunotherapies have dramatically improved outcomes even at stage 4. Some people live years longer than what was possible a decade ago.

The five-year survival rate for stage 4 kidney cancer sits around 12%. That sounds scary but doesn't tell the whole story. These statistics lag behind current treatments by several years. Newer medications approved recently show much better results. Plus, individual factors affect your personal outlook, your age, overall health, cancer subtype, and how well you respond to treatment.

Where Kidney Cancer Usually Spreads First?

Kidney cancer follows predictable patterns when spreading. Understanding these patterns helps you and your medical team watch for early signs and start treatment quickly.

Lungs are the number one destination for spreading kidney cancer, accounting for about 50-60% of cases. Cancer cells travel through blood vessels and settle in lung tissue. Early lung involvement might cause no symptoms and only shows up on imaging. As it grows, you might notice shortness of breath during activities, a persistent dry cough, or chest discomfort.

Bones rank second at about 30% of cases. Spine, ribs, pelvis, and long bones in arms and legs are common sites. Bone pain that worsens at night or doesn't improve with rest is the main symptom. Weakened bones fracture easily, sometimes from minor bumps or normal movement.

Other common spread locations:

• Liver (20% of cases) causing abdominal fullness, nausea, or yellowing skin

• Lymph nodes (15%) creating swollen lumps in neck, armpit, or groin areas

• Brain (10%) leading to headaches, seizures, vision changes, or personality shifts

• Adrenal glands (9%) sitting on top of kidneys, often causing no symptoms

• Opposite kidney (2-5%) presenting as a new mass on imaging

The location where cancer spreads first depends partly on blood flow patterns from your kidneys. Renal veins drain directly into the main vein carrying blood back to your heart and lungs, explaining why lungs get affected so frequently.

How doctors diagnose and stage kidney cancer

Diagnosing kidney cancer involves several steps. Your doctor starts with your medical history and physical exam. They ask about symptoms and feel your abdomen for unusual lumps or swelling. Blood tests check kidney function, look for anemia, and measure calcium levels.

Imaging tests provide the clearest picture of what's happening in your kidneys:

• Ultrasound uses sound waves to create images and often serves as the first test when doctors suspect kidney problems

• CT scan with contrast dye shows detailed views of kidney structure and can spot tumors as small as a few millimeters

• MRI provides excellent soft tissue detail and works well for people who can't have CT contrast

• PET scan helps determine if cancer has spread to other body parts

A biopsy involves taking a small tissue sample from the kidney tumor. Doctors use a thin needle guided by ultrasound or CT imaging. Not everyone needs a biopsy. If imaging clearly shows kidney cancer and surgery is planned, doctors often skip biopsy. They remove the tumor directly. Biopsy becomes necessary when imaging results are unclear or when deciding between surgery and other treatments.

Staging happens after diagnosis to determine how far cancer has spread. The TNM system doctors use looks at three factors. T describes tumor size and growth into nearby tissues. N indicates whether lymph nodes contain cancer. M shows if cancer has spread to distant organs. These factors combine into stages 1 through 4. Higher numbers mean more advanced disease.

Additional tests help complete staging:

• Chest X-ray or CT scan checks for lung involvement

• Bone scan reveals if cancer reached your skeleton

• Brain MRI looks for cancer in the brain if you have concerning neurological symptoms

The entire diagnostic process covers initial imaging to final staging. Getting a clear diagnosis and accurate staging guides treatment choices. It helps predict outcomes.

Are At-Home Urine Testing Useful in Detecting Kidney Cancer Early?

At-home urine test strips offer a helpful monitoring tool. But they come with important limitations. These strips can detect blood in urine before you see color changes with your eyes. This gives you an early warning that something needs attention.

Urine test strips work by changing color when they contact specific substances in your urine. For kidney cancer detection, the blood (hemoglobin) parameter matters most. When you dip a strip in your urine sample, a chemical reaction happens. The blood pad turns green or blue if red blood cells are present.

The benefits include:

• Catching microscopic blood that's invisible to your eye

• Providing quick results in 60 seconds

• Affordable monitoring at home between doctor visits

• Giving you documentation to share with your healthcare provider

• Detecting other markers like protein that signal kidney problems

However, at-home strips cannot diagnose kidney cancer. Blood in urine happens with many conditions. These include infections, kidney stones, exercise, and harmless causes. A positive test means you need follow-up with your doctor. It doesn't mean you definitely have cancer.

False positives occur when strips show blood that isn't really there. Vitamin C supplements, certain foods, and contamination from menstruation can cause incorrect results. False negatives happen too. Some kidney cancers don't bleed consistently. So normal test strips don't rule out cancer.

Use at-home strips wisely. Test first morning urine once a week if you have risk factors. Risk factors include family history or smoking. Keep a simple log of results. If you get a positive result, repeat the test the next day. Two positive tests in a row warrant a call to your doctor. They'll do professional urine analysis and possible imaging.

Can kidney cancer be cured? Treatment paths to know

Yes, kidney cancer can be cured, especially when caught early. Cure rates depend heavily on stage at diagnosis. Stage 1 kidney cancer has a five-year survival rate above 93%, meaning most people are alive and cancer-free five years after treatment.

Surgery remains the main curative treatment. Partial nephrectomy removes only the tumor and a small margin of healthy tissue around it, leaving most of the kidney intact. This works well for smaller tumors and preserves kidney function. Radical nephrectomy removes the entire kidney, nearby lymph nodes, and sometimes the adrenal gland. Living with one kidney is completely possible because the remaining kidney compensates.

Minimally invasive surgical techniques have changed kidney cancer treatment:

• Robotic-assisted surgery uses tiny incisions and offers faster recovery

• Laparoscopic approaches reduce pain and hospital stays

• Image-guided procedures work for small tumors in high-risk patients

For people who can't have surgery, ablation techniques destroy tumors without removing them. Cryoablation freezes cancer cells to death using extremely cold probes. Radiofrequency ablation burns tumors with heat energy. These work best for tumors smaller than 4 cm.

Advanced or spreading kidney cancer requires systemic treatments that work throughout your body. Targeted therapy drugs attack specific features of cancer cells, blocking blood vessel formation or interfering with growth signals. Immunotherapy helps your immune system recognize and fight cancer cells. These treatments don't usually cure advanced cancer but can control it for years, turning it into a manageable chronic condition.

Common targeted therapy medications:

• Sunitinib and pazopanib block signals that help tumors grow blood vessels

• Cabozantinib works on multiple pathways involved in cancer growth

• Axitinib often gets combined with immunotherapy for better results

Immunotherapy drugs like nivolumab and pembrolizumab have changed treatment dramatically. These medications take the brakes off your immune system, allowing it to attack cancer cells more effectively. Combining immunotherapy with targeted therapy produces better responses than either treatment alone.

Diagnosing kidney cancer involves several steps. Your doctor starts with your medical history and physical exam. They ask about symptoms and feel your abdomen for unusual lumps or swelling. Blood tests check kidney function, look for anemia, and measure calcium levels.

Imaging tests provide the clearest picture of what's happening in your kidneys:

• Ultrasound uses sound waves to create images and often serves as the first test when doctors suspect kidney problems

• CT scan with contrast dye shows detailed views of kidney structure and can spot tumors as small as a few millimeters

• MRI provides excellent soft tissue detail and works well for people who can't have CT contrast

• PET scan helps determine if cancer has spread to other body parts

A biopsy involves taking a small tissue sample from the kidney tumor. Doctors use a thin needle guided by ultrasound or CT imaging. Not everyone needs a biopsy. If imaging clearly shows kidney cancer and surgery is planned, doctors often skip biopsy. They remove the tumor directly. Biopsy becomes necessary when imaging results are unclear or when deciding between surgery and other treatments.

Staging happens after diagnosis to determine how far cancer has spread. The TNM system doctors use looks at three factors. T describes tumor size and growth into nearby tissues. N indicates whether lymph nodes contain cancer. M shows if cancer has spread to distant organs. These factors combine into stages 1 through 4. Higher numbers mean more advanced disease.

Additional tests help complete staging:

• Chest X-ray or CT scan checks for lung involvement

• Bone scan reveals if cancer reached your skeleton

• Brain MRI looks for cancer in the brain if you have concerning neurological symptoms

The entire diagnostic process covers initial imaging to final staging. Getting a clear diagnosis and accurate staging guides treatment choices. It helps predict outcomes.

Are At-Home Urine Testing Useful in Detecting Kidney Cancer Early?

At-home urine test strips offer a helpful monitoring tool. But they come with important limitations. These strips can detect blood in urine before you see color changes with your eyes. This gives you an early warning that something needs attention.

Urine test strips work by changing color when they contact specific substances in your urine. For kidney cancer detection, the blood (hemoglobin) parameter matters most. When you dip a strip in your urine sample, a chemical reaction happens. The blood pad turns green or blue if red blood cells are present.

The benefits include:

• Catching microscopic blood that's invisible to your eye

• Providing quick results in 60 seconds

• Affordable monitoring at home between doctor visits

• Giving you documentation to share with your healthcare provider

• Detecting other markers like protein that signal kidney problems

However, at-home strips cannot diagnose kidney cancer. Blood in urine happens with many conditions. These include infections, kidney stones, exercise, and harmless causes. A positive test means you need follow-up with your doctor. It doesn't mean you definitely have cancer.

False positives occur when strips show blood that isn't really there. Vitamin C supplements, certain foods, and contamination from menstruation can cause incorrect results. False negatives happen too. Some kidney cancers don't bleed consistently. So normal test strips don't rule out cancer.

Use at-home strips wisely. Test first morning urine once a week if you have risk factors. Risk factors include family history or smoking. Keep a simple log of results. If you get a positive result, repeat the test the next day. Two positive tests in a row warrant a call to your doctor. They'll do professional urine analysis and possible imaging.

Can kidney cancer be cured? Treatment paths to know

Yes, kidney cancer can be cured, especially when caught early. Cure rates depend heavily on stage at diagnosis. Stage 1 kidney cancer has a five-year survival rate above 93%, meaning most people are alive and cancer-free five years after treatment.

Surgery remains the main curative treatment. Partial nephrectomy removes only the tumor and a small margin of healthy tissue around it, leaving most of the kidney intact. This works well for smaller tumors and preserves kidney function. Radical nephrectomy removes the entire kidney, nearby lymph nodes, and sometimes the adrenal gland. Living with one kidney is completely possible because the remaining kidney compensates.

Minimally invasive surgical techniques have changed kidney cancer treatment:

• Robotic-assisted surgery uses tiny incisions and offers faster recovery

• Laparoscopic approaches reduce pain and hospital stays

• Image-guided procedures work for small tumors in high-risk patients

For people who can't have surgery, ablation techniques destroy tumors without removing them. Cryoablation freezes cancer cells to death using extremely cold probes. Radiofrequency ablation burns tumors with heat energy. These work best for tumors smaller than 4 cm.

Advanced or spreading kidney cancer requires systemic treatments that work throughout your body. Targeted therapy drugs attack specific features of cancer cells, blocking blood vessel formation or interfering with growth signals. Immunotherapy helps your immune system recognize and fight cancer cells. These treatments don't usually cure advanced cancer but can control it for years, turning it into a manageable chronic condition.

Common targeted therapy medications:

• Sunitinib and pazopanib block signals that help tumors grow blood vessels

• Cabozantinib works on multiple pathways involved in cancer growth

• Axitinib often gets combined with immunotherapy for better results

Immunotherapy drugs like nivolumab and pembrolizumab have changed treatment dramatically. These medications take the brakes off your immune system, allowing it to attack cancer cells more effectively. Combining immunotherapy with targeted therapy produces better responses than either treatment alone.

References

References

Agrawal, A., Sahni, S., Iftikhar, A., & Talwar, A. (2015). Pulmonary manifestations of renal cell carcinoma. Respiratory Medicine, 109(12), 1505–1508. https://doi.org/10.1016/j.rmed.2015.10.002 

Ballard, B. D., & Guzman, N. (2022). Renal Mass. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK567761/ 

Bisbee, C. A., Zhang, J., Owens, J., & Hussain, S. (2022). Cryoablation for the Treatment of Kidney Cancer: Comparison With Other Treatment Modalities and Review of Current Treatment. Cureus, 14(11). https://doi.org/10.7759/cureus.31195 

Chen, X.-Y., Lan, M., Zhou, Y., Chen, W.-Z., Hu, D., Liu, J.-M., Huang, S.-H., Liu, Z.-L., & Zhang, Z.-H. (2017). Risk factors for bone metastasis from renal cell cancer. Journal of Bone Oncology, 9, 29–33. https://doi.org/10.1016/j.jbo.2017.10.004 

Custódio, S., Joaquim, A., Peixoto, V., Joana Espiga Macedo, Ana Luísa Faria, Macias, E., Rego, S., & António Araújo. (2012). Metastatic Renal Cell Carcinoma: The Importance of Immunohistochemistry in Differential Diagnosis. Case Reports in Oncology, 5(1), 30–34. https://doi.org/10.1159/000335683 

Garg, P., Siddhika Pareek, Kulkarni, P., Horne, D., Ravi Salgia, & Singhal, S. S. (2024). Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment. Journal of Clinical Medicine, 13(21), 6537–6537. https://doi.org/10.3390/jcm13216537 

Harding, G., Cella, D., Robinson, D., Mahadevia, P. J., Clark, J., & Revicki, D. A. (2007). Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index. Health and Quality of Life Outcomes, 5(1). https://doi.org/10.1186/1477-7525-5-34 

Lindenberg, L., Mena, E., Choyke, P. L., & Bouchelouche, K. (2019). PET imaging in renal cancer. Current Opinion in Oncology, 31(3), 216–221. https://doi.org/10.1097/CCO.0000000000000518 

Ljungberg, B., Campbell, S., Cho, H. Y., Jacqmin, D., Lee, J. E., Weikert, S., & Kiemeney, L. (2011). The Epidemiology of Renal Cell Carcinoma. European Urology, 60(4), 615–621. https://doi.org/10.1016/j.eururo.2011.06.049 

Lutz, J. (2021). Pathophysiology, diagnosis, and treatment of membranous nephropathy. Néphrologie & Thérapeutique, 17, S1–S10. https://doi.org/10.1016/j.nephro.2021.03.001 

Mancini, M., Righetto, M., & Baggio, G. (2020). Gender-Related Approach to Kidney Cancer Management: Moving Forward. International Journal of Molecular Sciences, 21(9). https://doi.org/10.3390/ijms21093378 

National Cancer Institute. (2022, October 14). Cancer Staging. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/staging 

NCI Dictionary of Cancer Terms. (2025). Cancer.gov. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iii-kidney-cancer 

NHS. (2017, October 23). Kidney cancer - Symptoms. Nhs.uk. https://www.nhs.uk/conditions/kidney-cancer/symptoms/ 

Padala, S. A., Barsouk, A., Thandra, K. C., Saginala, K., Mohammed, A., Vakiti, A., Rawla, P., & Barsouk, A. (2020). Epidemiology of renal cell carcinoma. World Journal of Oncology, 11(3), 79–87. https://doi.org/10.14740/wjon1279 

Pandey, J., & Syed, W. (2023, August 8). Renal Cancer. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558975/ 

Ruys, A. T., Tanis, P. J., Iris, N. D., van Duijvendijk, P., Verhoef, C., Porte, R. J., & van Gulik, T. M. (2011). Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study. Annals of Surgical Oncology, 18(7), 1932–1938. https://doi.org/10.1245/s10434-010-1526-x 

Singh, A., Everest, S., Nguyen, L., & Hailemichael, T. (2021). Intractable Cough Associated With Renal Cell Carcinoma. Cureus. https://doi.org/10.7759/cureus.18727 

Takeuchi, M., McDonald, J. S., Takahashi, N., Frank, I., Thompson, R. H., King, B. F., & Kawashima, A. (2021). Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 5(2), 308–319. https://doi.org/10.1016/j.mayocpiqo.2020.12.001 

Vasudev, N. S., Wilson, M., Stewart, G. D., Adeyoju, A., Cartledge, J., Kimuli, M., Datta, S., Hanbury, D., Hrouda, D., Oades, G., Patel, P., Soomro, N., Sullivan, M., Webster, J., Selby, P. J., & Banks, R. E. (2020). Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open, 10(5). https://doi.org/10.1136/bmjopen-2019-035938 

Zhang, L., Yao, L., Li, X., Jewett, M. A. S., He, Z., & Zhou, L. (2016). Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment. Journal of the Formosan Medical Association, 115(6), 463–469. https://doi.org/10.1016/j.jfma.2015.05.003